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Background: Using demographic and clinical measures from emergency department evaluations, we
developed an automated surveillance system for influenza-like illness (ILI).
Methods: We selected a random sample of patients who were seen at the Durham, NC Veterans Affairs
Medical Center between May 2002 and October 2009 with fever or a respiratory ICD-9 diagnosis code and
divided this into subsets for system development and validation. Comprehensive chart reviews identified
patients who met a standard case definition for ILI. Logistic regression models predicting ILI were fit in the
development sample. We applied the parameter estimates from these models to the validation sample and
evaluated their utility using receiver-operator characteristic analysis.
Results: The models discriminated ILI very well in the validation sample; the C-statistics were  0.89.
Conclusions: Risk estimates based on statistical models can be incorporated into electronic medical records
systems to assist clinicians and could be used in real-time surveillance for disease outbreaks.
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I
nfluenza-like illnesses (ILI) are responsible for sig-
nificant morbidity and mortality, particularly in
people over 65 years of age (1 7). It is estimated
that seasonal influenza is responsible for 95,000 to
330,000 hospitalizations (2 4), as many as 70,000 deaths
in the United States annually (2, 5 7), and up to 500,000
deaths worldwide each year (8). Other major causes of
ILI such as rhinovirus, respiratory syncytial virus,
adenovirus, and parainfluenza virus are responsible for
a significant additional burden of hospitalization and
death (1, 4 6). The ILI also causes significant economic
burden in the United States with estimates of annual
direct medical costs of $10 billion and an overall yearly
cost of $87 billion when accounting for lost wages and
years of lost life (1, 9 11).
Timely and accurate surveillance for ILI is an im-
portant component of the public health efforts to
respond to outbreaks, as evidenced by the rapid devel-
opment of the novel H1N1 into a pandemic during 2009.
Since the signs and symptoms of ILI are relatively non-
specific, potential cases are often identified on the basis
of acute respiratory symptoms, fever, and possibly other
measures. Definitive identification of cases is made by
either laboratory testing of patient samples for specific
microorganisms or a manual chart review for additional
symptoms (12 15), both of which are labor-intensive and
time-consuming and may lead to delayed clinical and
public health response.
In this analysis, we present an automated system for
identifying patients with ILI using the Department of
Veterans Affairs electronic clinical database and the NC
Veterans Electronic Testbed (NCVET), an infectious
disease specific database that was developed at the
Durham VA Medical Center. Specifically, we developed
and validated several statistical models predicting ILI
based on electronic clinical information available at the
time of presentation to the Durham VA emergency
department or acute care clinic. Our aim was to use
(page number not for citation purpose)
 ORIGINAL ARTICLE
Emerging Health Threats Journal 2011. # 2011 Lawrence P. Park et al. This is an Open Access article distributed under the terms of the Creative Commons
Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction
in any medium, provided the original work is properly cited.
1
Citation: Emerging Health Threats Journal 2011, 4: 7108 - DOI: 10.3402/ehtj.v4i0.7108automated, electronically available data to better discri-
minate those with ILI from those with other unrelated
conditions among the population who presented with
either fever or respiratory symptoms.
Methods
Study population and data extraction
The sample for this study was drawn from the patients
who presented to the Durham VA Medical Center
(VAMC) emergency department or acute care clinic
between May 2002 and October 2009 with either fever
]388C or an ICD-9 code for acute respiratory illness;
these are the existing manual ILI screening criteria for the
facility. At the Durham VAMC, the primary reasons for a
clinical encounter are assigned ICD-9 codes by the
treating physician at the time of the encounter. We used
the ICD-9 codes for acute respiratory illness shown in
Appendix Table 1 (16).
Allpatientmedicalrecordinformationisenteredinreal-
time and are maintained in the VA Computerized Patient
Record System (CPRS). Our investigators performed a
chart reviewof the CPRS data available for the patients at
thetimeoftheirevaluationandrecordedtheinformationof
interest to this study including chief complaint and
assigned ICD-9 code, age, signs and symptoms (fever]
388C, respiratory ICD-9 code, cough, sore throat, short-
ness of breath, myalgias, chills/sweats, headache, fatigue),
antibioticanddecongestantprescriptions,andchestradio-
graph orders. Chief complaint, ICD-9 code were coded as
text, age was categorized in four levels (B50, 50 59, 60 
69,]70) and all other variables were coded as present/
absent. Inaddition, eachpatient wasdetermined ashaving
ILI or not using the North Carolina Division of Public
Health case definition for ILI (17, 18), which is one
respiratory symptom (cough, cyanosis, difficulty breath-
ing, hemoptysis, hypoxia, pleural effusion, pleurisy, pneu-
monia, respiratory stridor, dyspnea, tachypnea) and one
constitutional sign (achy, body aches, chills/shivers/rigors/
shakes, diaphoresis/sweaty, dizziness, drowsy/sleepy/tired/
exhausted/fatigue, fever (]388C)/febrile/FUO/tempera-
ture, hurts all over, joint pain, light headed, loss of
appetite/poor/decreased/no appetite, malaise, muscle
aches, myalgia, prostration, weariness, wooziness). See
Appendix Table 2 for the complete case definition (17, 18).
Because a complete chart review of all patients
presenting with fever or respiratory symptoms was
impractical, we reviewed a total of 1,116 patients, 750
from the period May 2002 to June 2007 and 366 from
July 2007 to October 2009. The absolute number of
patients who presented with both fever and respiratory
symptoms was much smaller than those with fever only,
and this in turn was smaller than those with respiratory
symptoms only. Patients were selected randomly and
separately for the two time periods using stratified
sampling to obtain approximately equal numbers of
patients for each stratum; the sampling probabilities in
each time period were 0.135 for those with fever only,
0.024 for those with respiratory symptoms only, and
0.700 for those with both fever and respiratory ICD-9
code. We used the larger sample from the earlier time
period for model development, while data from the later
period served as a validation set.
Statistical methods
Associations between ILI and the demographic and
clinical variables were assessed with contingency tables
and bivariable logistic models. Several multiple logistic
regression models were fit to determine the set of clinical
variables that best predict patients who met the North
Carolina ILI criteria. A basic model included parameters
for fever and respiratory ICD-9 code only. A full model
included all of the clinical parameters available at ED
evaluation. A more parsimonious model was developed
using stepwise, backward elimination of variables from
the full model and included only those variables that were
significant at p50.05. A final model removed from the
parsimonious model the prescription and radiograph
variables, since these might not be immediately available
at the evaluation of the patient. We used weighted logistic
regression methods for survey data to account for the
differential sampling probabilities and obtain variance
estimates adjusted for the sampling design defined by
strata of fever and acute respiratory complaints.
The relative performance of the development models
was evaluated by comparing the receiver-operator
characteristic (ROC) curves and C statistic (AUC or the
area under the curve) for these models. The ROC analysis
was also used to examine the validity of the development
models as follows. The vector of parameter estimates
from the development models was applied to the vector of
variables for the patients in the validation sample to
create a risk score for each individual. Then, the
sensitivity, specificity, ROC curves, and AUC were
calculated in the validation sample on a series of
dichotomizations of ILI or not for each value in the
range of risk scores. These results were compared for the
development and validation samples.
All analyses were carried out with SAS 9.2 (Cary, NC).
The research protocol for this study was approved by
the Durham VAMC’s Institutional Review Board in
November 2006 (Research Protocol #0016).
Results
Comparison of ILI and covariates in the development
and validation samples
After weighting the development sample, 3,423 (32.1%)
of 10,667 patients evaluated in the ED met the NC case
definition for ILI. The proportions of ILI among the
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(266 of 1,211) for fever only, (2) 30.4% (2,739 of 9,005) for
acute respiratory ICD-9 code, and 92.7% (418 of 451) for
those with both. Similar proportions were found in the
validation sample, where 1,677 (30.7%) of 5,464 patients
had ILI by the NC definition and these were distributed
as: (1) 22.4% (217 of 967) for fever only, (2) 29.4% (1,244
of 4,229) for acute respiratory ICD-9 code, and (3) 80.6%
(216 of 268) for those with both. In both samples, those
with both fever and respiratory symptoms met the case
definition at much higher rates than those with either of
these alone.
The distributions of the symptoms and medical
management variables in the development and validation
samples are shown in Table 1. The patients in these
samples differed somewhat in age distribution and those
in the validation set had higher rates of fever, chills/
sweats, and fatigue. Patient management also differed
between the two time periods, with higher rates of X-ray
and fewer prescriptions of decongestants in the more
recent validation sample.
Predictive model performance
The parameter estimates from the four models are shown
in Table 2 and the ROC curves in Fig. 1. Model 1 with
only fever and respiratory symptoms as predictors
performed less well relative to the other models, but the
C statistic of 0.846 indicates that it fits the data well,
nonetheless. The performance of models 2, 3, and 4 were
essentially equivalent, as indicated by the coincident
ROC curves and nearly identical C statistics.
Table 2. Bivariate associations and parameter estimates from the development models predicting inﬂuenza-like illness.
Estimate (Standard Error)
Bivariate association Model 1 Model 2 Model 3 Model 4
Intercept  4.62 (0.19)  13.31 (0.40)  13.60 (0.39)  13.17 (0.38)
Age (years)
a
B 50 1 1
50   59  0.49 (0.32)  0.46 (0.11)
60   69  0.48 (0.38)  0.61 (0.13)
] 70  0.72 (0.36)  0.51 (0.13)
Fever 0.47 (0.17) 3.35 (0.18) 5.79 (0.28) 5.76 (0.28) 5.90 (0.28)
Resp ICD-9 code 0.58 (0.22) 3.79 (0.19) 5.51 (0.31) 5.51 (0.31) 5.83 (0.31)
Cough 1.98 (0.32) 3.68 (0.15) 3.61 (0.14) 3.91 (0.13)
Sore throat 1.88 (0.30) 2.39 (0.11) 2.39 (0.11) 2.32 (0.10)
Dyspnea  0.85 (0.30) 0.01 (0.11)
Myalgia 2.71 (0.44) 4.99 (0.17) 4.99 (0.17) 4.94 (0.16)
Chills/sweats 2.38 (0.31) 4.02 (0.12) 4.02 (0.11) 4.12 (0.11)
Headache 1.59 (0.35) 3.60 (0.13) 3.60 (0.12) 3.83 (0.12)
Fatigue 2.27 (0.42) 4.42 (0.16) 4.35 (0.15) 4.53 (0.15)
Antibacterial 1.04 (0.25) 1.29 (0.09) 1.24 (0.09)
Decongestant 1.30 (0.28) 1.11 (0.10) 1.08 (0.10)
Chest X-ray 0.57 (0.27)  0.03 (0.11)
a Age categories parameterized as indicator variables, with reference level B50.
Table 1. Comparison of demographic and clinical character-
istics of the VA patient populations from which the model
development and validation samples were drawn
Parameter Development
(%)
Validation
(%)
Fisher’s
exact p-value
Age (years)
B50 23.5 22.1 0.007
50 59 33.9 24.0
60 69 18.1 31.7
]70 34.4 22.2
Fever 15.6 22.6 0.003
Respiratory Sx 88.6 82.3 0.002
Cough 67.3 66.4 0.828
Sore throat 23.5 26.7 0.448
Dyspnea 26.5 31.7 0.247
Myalgia 13.6 18.0 0.210
Chills/sweats 19.0 27.6 0.031
Headache 13.1 9.7 0.278
Fatigue 9.5 16.7 0.019
Antibacterial 45.7 44.5 0.807
Decongestant 28.4 6.4 B0.0001
Chest X-ray 24.9 42.9 B0.0001
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Citation: Emerging Health Threats Journal 2011, 4: 7108 - DOI: 10.3402/ehtj.v4i0.7108 3
(page number not for citation purpose)Evaluation of the models in the validation sample
The performance of development models in the valida-
tion sample was excellent. The estimates from these
models on the validation set gave C statistics of 0.757
for model 1 and 0.894 for the other three models. The
ROC curves comparing model 4 in the development and
validation samples shown in Fig. 2 illustrate the good
concordance of the model in the two datasets. The fit for
the other three models was similar.
Discussion
We have developed and validated several models that
classify ILI in patients presenting to our emergency
department. Including a set of symptoms and manage-
ment practices that are commonly, but not exclusively,
associated with ILI improved the model fit and discrimi-
nated ILI better than the current screening based on fever
and respiratory symptoms alone. Accurate diagnosis of
ILI is important for guiding appropriate clinical manage-
ment of patients who have, and those who do not have,
ILI. In addition, the novel H1N1 influenza pandemic that
developed over the last year illustrated the need for rapid
and accurate reporting of ILI for public health efforts.
This study required a chart review of the triage, chief
complaint, and physician notes to acquire the analysis
data. For this study, we did this manually, which is a time-
consuming process. Since the clinical data are available
electronically in real-time at VA Medical Centers, natural
language processing methods could be used on free-text
notes to extract the information used in these models, and
the model results could be incorporated into the VA data
systems to automate and immediately flag patients
who are likely to have ILI. Numerous examples of
natural language processing and disease classification
systems have been developed for clinical purposes (19 22)
and for syndromic surveillance (22 25).
While we have demonstrated the utility of predictive
modeling for a straightforward illness, this method could
be adapted to surveillance for other infections and
clinical syndromes including natural infectious disease
outbreaks, surgical site infections, and disease clusters
caused by infrequently encountered agents that might be
used in a bioterrorist attack (26, 27). Developing formal
predictive models for bioterrorism agents would be more
difficult than for natural outbreaks due to a lack of cases
to use in developing models. As an alternative, a scoring
system could be developed using the symptoms known to
be associated with other agents, and these parameters
could be weighted based on how common they are in
affected individuals (27).
Although the models we constructed here were shown
to be valid when applied to a temporally distinct sample
of the same patient population, a caveat to this study
is that the results are not necessarily extensible to other
patient populations. The VA patients are older than
patients seen at non-VA facilities and the elderly can
present very differently than younger people. In addition,
women are under-represented in the VA population, and
veterans generally have more health problems than the
general population.
Temporal differences in patient populations can also
affect the validity of these models. Over the time period of
this study, we noted two changes in the VA patient
population. First, due to a shift toward relatively fewer
WW II and more Viet Nam era veterans, the age
Fig. 1. Comparison of ROC curves for the four development
models. Variables included in the models are shown in Table 2.
The ROC curves and values for the area under the ROC curve
(AUC) were obtained from the multivariable logistic regression
models.
Fig. 2. Comparison of the ROC curves for model 4 in the
development and validation samples. The parameter estimates
from the development model 4 were applied to the validation
sample data to calculate the sensitivity, speciﬁcity, and area
under the ROC curve (AUC).
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more in the 60 69 year stratum. Second, our VA medical
center engaged in a successful effort to encourage patients
to use VA-associated regional outpatient clinics rather
than the Durham VAMC emergency department. To-
gether, these changes may account for the differences in
presentation and management of patients: if the less sick
patients now preferentially use the regional clinics, then
the Durham facility patients could now be sicker, leading
to more symptoms and more aggressive clinical evalua-
tion and management. Given the potential for temporal
changes in populations, predictive models like the ones
used here should be re-evaluated periodically.
An important aspect of this study is the use of real-
time clinical data available in the VA medical system.
Including predictive models in the data system can allow
for rapid and automated identification of syndromes that
might be associated with disease outbreaks. As more
hospitals deploy electronic clinical data systems, surveil-
lance for important infections and diseases could be
improved.
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tory illness from the VA database
ICD-9 code Description
32 Diphtheria
34 Streptococcal sore throat and Scarlet Fever
74 Specific diseases due to Coxsackie virus
460 Acute nasopharyngitis (common cold)
461 Acute sinusitis
462 Acute pharyngitis
463 Acute tonsillitis
464 Acute laryngitis and tracheitis
465 Acute upper respiratory infections of multiple or
unspecified sites
466 Acute bronchitis and bronchiolitis
478 Other diseases of upper respiratory tract
480 Viral pneumonia
481 Pneumococcal pneumonia (Streptococcus
pneumoniae pneumonia)
482 Other bacterial pneumonia
483 Pneumonia due to other specified organism
484 Pneumonia in infectious diseases classified
elsewhere
485 Bronchopneumonia, organism unspecified
486 Pneumonia, organism unspecified
487 Influenza
488 Influenza due to identified avian influenza virus
490 Bronchitis, not specified as acute or chronic
494 Bronchiectasis
34.0 Streptococcal sore throat
79.0 Adenovirus
79.1 ECHO virus
79.2 Coxsackie virus
79.3 Rhinovirus
79.6 Respiratory syncytial virus (RSV)
79.98 Unspecified chlamydial infection
79.99 Unspecified viral infection
518.0 Pulmonary collapse
518.4 Acute edema of lung, unspecified
518.81 Acute respiratory failure
518.82 Other pulmonary insufficiency, not elsewhere
classified
518.84 Acute and chronic respiratory failure
519.3 Other diseases of mediastinum, not elsewhere
classified
784.1 Throat pain
786 Dyspnea and respiratory abnormalities
786.00 Respiratory abnormality, unspecified
786.05 Shortness of breath
786.06 Tachypnea
786.07 Wheezing
786.1 Stridor
786.2 Cough
786.3 Hemoptysis
786.4 Abnormal sputum
786.52 Painful respiration
Appendix Table 2. Case deﬁnition for inﬂuenza-like illness (ILI)
Initiated 11/19/03
Revised 12/8/03, 2/24/04, 5/5/04, 10/31/04, 2/13/06, 2/24/06,
3/8/06
Source: NC Division of Public Health
Clinical description
Acute (514 days) onset of lower respiratory tract disease (from
larynx to lungs)
Excludes certain chronic conditions
Specific signs and symptoms
Must have at least one respiratory AND one constitutional sign or
symptom
May also have other symptoms
1. Respiratory: cough, cyanosis, difficulty breathing,
hemoptysis, hypoxia, pleural effusion, pleurisy, pneumonia,
respiratory stridor, shortness of breath/SOB/dyspnea,
tachypnea/increased respiratory rate
2. Constitutional: achy, body aches, chills/shivers/rigors/shakes,
diaphoresis/sweaty, dizziness, drowsy/sleepy/tired/
exhausted/fatigue, fever/febrile/FUO (temperature]388C),
hurts all over, joint pain, light headed, loss of appetite/ poor/
decreased/no appetite, malaise, muscle aches, myalgia,
prostration, weariness, wooziness
In addition, any of these conditions by themselves is considered
ILI: anthrax, plague, SARS, tularemia, influenza
Comments:
 Excluded conditions: CHF
 Diagnoses of particular concern:
  Category A agents: anthrax, plague, tularemia
  Other diagnoses of public health priority: SARS, influenza
  Chemical agents:
k Vesicants/blister agents: sulfur mustard, lewisite,
nitrogen mustard, mustard lewisite, phosgene-oxime
k Pulmonary/choking agents: phosgene, chlorine,
diphosgene, chloropicrin, oxide of nitrogen, sulfur
dioxide
  Ricin (Castor bean oil extract)
  T-2 mycotoxins: Fusarium, Myrotecium, Trichoderma,
verticimonosporium, Stachybotrys
Automated ILI detection at a Veterans Affairs Medical Center
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